Role of EGF inhibitors in the treatment of recurrent or metastatic squamous cell head and neck cancer

Squamous cell cancer of the head and neck (SCCHN) is a major contributor to morbidity and mortality worldwide. In recent years, inhibition of the epidermal growth factor receptor has become an established treatment strategy in SCCHN both in the up-front treatment and in the recurrent and metastatic...

Descripción completa

Detalles Bibliográficos
Autor principal: Lorch, Jochen H
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004660/
https://www.ncbi.nlm.nih.gov/pubmed/21188133
_version_ 1782194020128129024
author Lorch, Jochen H
author_facet Lorch, Jochen H
author_sort Lorch, Jochen H
collection PubMed
description Squamous cell cancer of the head and neck (SCCHN) is a major contributor to morbidity and mortality worldwide. In recent years, inhibition of the epidermal growth factor receptor has become an established treatment strategy in SCCHN both in the up-front treatment and in the recurrent and metastatic setting. This review summarizes the most important developments of the recent past and provides an overview of newer developments.
format Text
id pubmed-3004660
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-30046602010-12-23 Role of EGF inhibitors in the treatment of recurrent or metastatic squamous cell head and neck cancer Lorch, Jochen H Cancer Manag Res Review Squamous cell cancer of the head and neck (SCCHN) is a major contributor to morbidity and mortality worldwide. In recent years, inhibition of the epidermal growth factor receptor has become an established treatment strategy in SCCHN both in the up-front treatment and in the recurrent and metastatic setting. This review summarizes the most important developments of the recent past and provides an overview of newer developments. Dove Medical Press 2009-11-03 /pmc/articles/PMC3004660/ /pubmed/21188133 Text en © 2009 Lorch, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Review
Lorch, Jochen H
Role of EGF inhibitors in the treatment of recurrent or metastatic squamous cell head and neck cancer
title Role of EGF inhibitors in the treatment of recurrent or metastatic squamous cell head and neck cancer
title_full Role of EGF inhibitors in the treatment of recurrent or metastatic squamous cell head and neck cancer
title_fullStr Role of EGF inhibitors in the treatment of recurrent or metastatic squamous cell head and neck cancer
title_full_unstemmed Role of EGF inhibitors in the treatment of recurrent or metastatic squamous cell head and neck cancer
title_short Role of EGF inhibitors in the treatment of recurrent or metastatic squamous cell head and neck cancer
title_sort role of egf inhibitors in the treatment of recurrent or metastatic squamous cell head and neck cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004660/
https://www.ncbi.nlm.nih.gov/pubmed/21188133
work_keys_str_mv AT lorchjochenh roleofegfinhibitorsinthetreatmentofrecurrentormetastaticsquamouscellheadandneckcancer

Ejemplares similares